![]() |
|
|
Vol. 293, Issue 2, 321-328, May 2000
Molecular Pharmacology Unit, Alcon Research, Ltd., Fort Worth,
Texas
The prostanoid receptor-subtype binding affinities,
selectivities, potencies, and intrinsic activities of four natural
prostanoids and six synthetic DP class prostanoids were
determined using binding and functional assays with endogenous
receptors. SQ27986 exhibited the highest affinity for the human
platelet DP receptor and the best DP receptor selectivity profile.
Prostaglandin (PG)D2 was the least DP receptor-selective.
The rank order of compound affinities at the DP receptor was SQ27986
(Ki = 10 ± 2 nM) > RS93520 = ZK110841 = BW245C
(Ki = 23-26 nM) > ZK118182
(Ki = 50 ± 9 nM) > PGD2 (Ki = 80 ± 5 nM). DP receptor agonists produced cAMP in embryonic bovine tracheal
fibroblasts with different potencies (EC50 values in nM):
ZK118182 (18 ± 6), RS93520 (28 ± 6), SQ27986 (29 ± 7), ZK110841 (31 ± 7), BW245C (53 ± 16), and
PGD2 (98 ± 10). BW245C was more efficacious and
RS93520 was less efficacious than PGD2. ZK110841 and
ZK118182 exhibited a relatively high potency at the adenylyl
cyclase-coupled EP2 receptor in human nonpigmented ciliary epithelial cells but were partial agonists. None of the DP class agonists showed any EP4 receptor functional activity in
Chinese hamster ovary cells. The DP receptor antagonist BWA868C
competitively antagonized the PGD2-induced cAMP
accumulation in embryonic bovine tracheal fibroblast cells
(pA2 = 7.83 ± 0.08). The dissociation constants
for BWA868C antagonizing PGD2-, BW245C-, and
ZK118182-induced cAMP production were quite similar (apparent
log
Kb = 7.9-8.2, n = 5-9). The pharmacological properties of some natural and numerous DP
class synthetic prostanoids have been determined using endogenous receptors.
This article has been cited by other articles:
![]() |
P. Schratl, J. F. Royer, E. Kostenis, T. Ulven, E. M. Sturm, M. Waldhoer, G. Hoefler, R. Schuligoi, I. Th. Lippe, B. A. Peskar, et al. The Role of the Prostaglandin D2 Receptor, DP, in Eosinophil Trafficking J. Immunol., October 1, 2007; 179(7): 4792 - 4799. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Mohri, M. Taniike, H. Taniguchi, T. Kanekiyo, K. Aritake, T. Inui, N. Fukumoto, N. Eguchi, A. Kushi, H. Sasai, et al. Prostaglandin D2-mediated microglia/astrocyte interaction enhances astrogliosis and demyelination in twitcher. J. Neurosci., April 19, 2006; 26(16): 4383 - 4393. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kohyama, T. A. Wyatt, X. Liu, F.-Q. Wen, T. Kobayashi, Q. Fang, H. J. Kim, and S. I. Rennard PGD2 Modulates Fibroblast-Mediated Native Collagen Gel Contraction Am. J. Respir. Cell Mol. Biol., September 1, 2002; 27(3): 375 - 381. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Arimura, K. Yasui, J. Kishino, F. Asanuma, H. Hasegawa, S. Kakudo, M. Ohtani, and H. Arita Prevention of Allergic Inflammation by a Novel Prostaglandin Receptor Antagonist, S-5751 J. Pharmacol. Exp. Ther., August 1, 2001; 298(2): 411 - 419. [Abstract] [Full Text] [PDF] |
||||